You are here: Industry Insights > Piramal Pharma Solutions

News List

Piramal Pharma Solutions Expands & Upgrades UK Facilities contractpharma
February 08, 2022
£55 million investment includes a multipurpose ADC manufacturing and aseptic fill/finish facility in Grangemouth and enhanced API manufacturing in Morpeth.
Piramal to create screening facility to boost in-vitro biology capabilities CPhIonline
January 14, 2022
The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities.
Piramal Opens Solid Oral Dosage Facility in Sellersville, PA contractpharma
September 22, 2020
Site adds North American capability in product and process development, manufacturing and packaging of solid oral dosage forms, liquids, creams, and ointments.
Piramal Pharma Solutions to join hands with Epirium Bio to develop and manufacture orphan drugs expresspharma
August 28, 2020
The integrated programme, involving three Piramal Pharma Solutions sites, encompasses formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
Piramal Pharma Solutions unveils cGMP kilo lab suite for API expressbpd
November 22, 2018
The suite in Chennai will formally open on December 1, 2018
Piramal Pharma solutions names John Fowler as chief operating officer pharmaasia
September 14, 2017
John Fowler will be responsible for Global Operations and Research & Development (R&D).
Piramal Pharma Solutions names John Fowler as its COO expressbpd
September 11, 2017
Fowler will be responsible for global operations and R&D and will play a lead role in ensuring that customers consistently experience differentiated and excellent levels of service
John Fowler appointed as the Chief Operating Officer of Piramal Pharma Solutions biospectrumasia
September 11, 2017
As Chief Operating Officer, John will be responsible for Global Operations and Research & development (R&D)